Bionano Genomics, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €69.00M +22.1% €5.42M -167.1% 7.9% +0.22 pp N/A N/A
    (estimated) €56.49M +26.3% -€8.08M -51.1% -14.3% +0.23 pp N/A N/A
    (estimated) €44.73M +38.2% -€16.53M -32.7% -37.0% +0.39 pp N/A N/A
    (estimated) €32.36M +32.0% -€24.57M +13.3% -75.9% +0.13 pp N/A N/A
    (estimated) €24.51M -7.6% -€21.69M -77.5% -88.5% +2.8 pp N/A N/A
    €26.52M -14.8% -€96.51M -51.8% -364.0% +2.8 pp -€59.29M -44.3% -223.6% +1.2 pp
    €31.12M +29.9% -€200.30M +75.3% -643.7% -1.7 pp -€106.39M +1.6% -341.9% +0.95 pp
    €23.95M +54.6% -€114.24M +83.1% -476.9% -0.74 pp -€104.69M +72.4% -437.1% -0.45 pp
    €15.49M +111.5% -€62.41M +76.1% -402.8% +0.81 pp -€60.71M +83.9% -391.9% +0.59 pp
    €7.33M -16.1% -€35.44M +37.9% -483.8% -1.9 pp -€33.01M +30.0% -450.6% -1.6 pp
    €8.73M -15.6% -€25.71M +61.3% -294.5% -1.4 pp -€25.39M +50.3% -290.9% -1.3 pp
    €10.34M +26.3% -€15.94M -20.8% -154.1% +0.92 pp -€16.90M -0.9% -163.4% +0.45 pp
    €8.19M +39.9% -€20.13M +24.0% -245.8% +0.32 pp -€17.06M -10.6% -208.3% +1.2 pp
    €5.85M -€16.24M -277.5% -€19.08M -326.0%

    Notifications